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Background and purpose: To evaluate non-coplanar volumetric modulated arc radiotherapy (VMAT) tra-
jectories for organ at risk (OAR) sparing in primary brain tumor radiotherapy.
Materials and methods: Fifteen patients were planned using coplanar VMAT and compared against non-
coplanar VMAT plans for three trajectory optimization techniques. A geometric heuristic technique (GH)
combined beam scoring and Dijkstra’s algorithm to minimize the importance-weighted sum of OAR vol-
umes irradiated. Fluence optimization was used to perform a local search around coplanar and GH tra-
jectories, producing fluence-based local search (FBLS) and FBLS + GH trajectories respectively.
Results: GH, FBLS, and FBLS + GH trajectories reduced doses to the contralateral globe, optic nerve, hip-
pocampus, temporal lobe, and cochlea. However, FBLS increased dose to the ipsilateral lens, optic nerve
and globe. Compared to GH, FBLS + GH increased dose to the ipsilateral temporal lobe and hippocampus,
contralateral optics, and the brainstem and body. GH and FBLS + GH trajectories reduced bilateral hip-
pocampi normal tissue complication probability (p = 0.028 and p = 0.043, respectively). All techniques
reduced PTV conformity; GH and FBLS + GH trajectories reduced homogeneity but less so for FBLS + GH.
Conclusions: The geometric heuristic technique best spared OARs and reduced normal tissue complica-
tion probability, however incorporating fluence information into non-coplanar trajectory optimization
maintained PTV homogeneity.
 2016 The Authors. Published by Elsevier Ireland Ltd. Radiotherapy and Oncology 121 (2016) 124–131
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Sparing organs at risk (OAR) in intracranial radiotherapy
reduces the risk of side effects that affect quality of life, such as cra-
nial and optic neuropathy, hearing loss, and neurocognitive
impairment [1–6]. Using non-coplanar beam orientations has been
shown to improve OAR dosimetry in conformal [7], intensity mod-
ulated (IMRT) [8], and volumetric modulated arc (VMAT) [9] radi-
ation therapy. However, non-coplanar geometries are fixed during
delivery for a given beam, limiting their application to VMAT. New
linear accelerators can perform dynamic couch rotation during
beam delivery, making possible non-coplanar VMAT trajectories
that use more of the 4p space around the patient [10–12] and
enabling potential additional reductions in normal tissue compli-
cation probability (NTCP).
Early research into the clinical benefit of non-coplanar VMAT
mainly focused on planner-defined trajectories [13–15], whilerecent work has investigated trajectory optimization techniques
[10,16–19]. Published optimization techniques have used one of
two approaches: geometric heuristics or fluence optimization.
Geometric heuristics score individual beam orientations and deter-
mine trajectories that minimize the overall score [10,16,17].
Fluence-based techniques identify a smaller group of optimal can-
didate beam orientations, which are then connected via intermedi-
ate paths [18,19]. Geometric heuristics are appealing due to the
computational complexity of a full fluence search for a VMAT arc
but lack the dosimetric information that can be utilized in fluence
optimization.
This paper proposes and evaluates three different trajectory
optimization techniques - a geometric heuristic technique and
two incorporating fluence optimization - for primary brain tumor
radiotherapy using non-coplanar VMAT. We aim to answer three
questions:
(1) Does a geometric heuristic technique improve OAR sparing
over coplanar VMAT?
G. Smyth et al. / Radiotherapy and Oncology 121 (2016) 124–131 125(2) Does a fluence-based local search technique improve OAR
sparing over coplanar VMAT?
(3) Is there a synergistic effect if the geometric heuristic and
fluence-based local search techniques are combined?
This work quantifies the clinical effect of new techniques for
optimizing non-coplanar VMAT and aims to widen the therapeutic
window of radiotherapy for primary brain tumors. We demon-
strate that a less computationally intense geometric heuristic tech-
nique is sufficient to produce high quality plans. Our goal is to
facilitate the introduction of non-coplanar VMAT into neuro-
oncology clinical practice.Gantry angle (°)
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Patient selection and treatment planning
Fifteen patients treated with radiotherapy for primary brain
tumors were planned using VMAT. Mean and standard deviation
planning target volume (PTV) size was 336.6 ± 214.1 cc (range
5.5–723.6 cc), with a CTV-PTV margin of 3 mm in all cases. Original
PTV prescription doses were 60 Gy in 2 Gy fractions, and 54 Gy or
59.4 Gy in 1.8 Gy fractions. One patient had palliative treatment
(30 Gy in 6 Gy fractions) but was replanned to an appropriate rad-
ical dose (60 Gy in 2 Gy fractions) for this study. Further informa-
tion for each patient case is contained in Supplementary Table A1.
Coplanar and non-coplanar radiotherapy plans were produced for a
6 MV Elekta Synergy linear accelerator (Elekta AB, Stockholm,
Sweden) with Agility multi-leaf collimator [20]. Coplanar VMAT
planning used our standard clinical technique of a single arc with
180 control points, however to avoid bias due to the additional
degrees of freedom available to non-coplanar methods, dual arc
coplanar plans with 360 control points were also produced.
Plans were optimized using an in-house VMAT planning system
[21,22] (AutoBeam v5.5a), adapted to import complex couch tra-
jectories [16]. The planning process is summarized here, with the
detailed workflow included in Supplementary Fig. A1. AutoBeam
performed fluence optimization at each control point before
sequencing the fluence maps into deliverable connected VMAT
apertures. As sequencing degraded the dose distribution, direct
aperture optimization was performed subject to machine limits
for VMAT delivery. Further detail on AutoBeam and the optimiza-
tion techniques used at each stage can be found elsewhere [21,22].
All cases used the same optimization objectives (Supplemen-
tary Table A2) to ensure a fair comparison. AutoBeam plans were
reconstructed in Pinnacle3 (Pinnacle3 v9.8, Philips Medical, Madi-
son, WI) for final dose calculation in line with clinical practice.
Dose was prescribed to the PTV mean value and calculated on a
2.5  2.5  2.5 mm3 resolution dose grid using the Adaptive Con-
volve algorithm.Gantry angle (°)
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Fig. 1. Non-coplanar trajectory optimization methods for (a) the geometric
heuristic technique (GH), and (b) the fluence-based local search (FBLS) algorithm.
Followed left to right, (b) shows how the FBLS algorithm updates at each numbered
step. As the example shown uses GH as its initial trajectory, (b) would produce a
FBLS + GH trajectory. All trajectories are overlaid on the normalized GH cost map.
White regions indicate excluded potential collision regions; high cost regions
indicate orientations where a beam aperture conforming to the PTV would irradiate
multiple or high importance organs at risk. In (b), black and gray circles indicate
current and previously considered beam orientations respectively; the dashed line
indicates the new trajectory.Trajectory optimization
Three non-coplanar VMAT trajectory optimization techniques
were developed in MATLAB (R2010b, The MathWorks, Natick,
MA): a geometric heuristic technique (GH), a fluence-based local
search technique (FBLS), and the combination of GH and FBLS
(FBLS + GH). Organs at risk used in trajectory optimization were
the brainstem, globes, optic nerves, optic chiasm, lenses, hip-
pocampi, temporal lobes, cochleae, and the volume of brain
excluding the PTV and other OARs. A patient voxel size of
5  5  5 mm3 was used during trajectory optimization. For ray
tracing, a beam aperture was defined as the projection of the PTV
onto the isocenter plane and rays were cast through the center of
2.5  2.5 mm2 beam elements. A 2 mm margin was applied tothe optic nerves, lenses, optic chiasm, and cochleae during trajec-
tory optimization to prevent small OARs being missed in this step.Geometric heuristic technique
The geometric heuristic technique (Fig. 1(a)) is an extension of
the algorithm described in [16]; further detail is provided in Sup-
plementary Fig. A1. Ray tracing was performed through the patient
to determine a cost based on OAR geometry for all achievable
isocentric beam orientations (Fig. 1(a), step 1). The trajectory opti-
mization was formulated as a graph search problem, with the cost
for a given beam orientation being the penalty applied for adding
that orientation to the VMAT trajectory, and solved using Dijkstra’s
least-cost path algorithm [23] (Fig. 1(a), step 2). Single arc trajecto-
ries were produced through 358 of gantry rotation, from 179 to
181, with control points spaced every 2 of gantry or couch rota-
tion. Sections of trajectory with continuous couch rotation but sta-
tic gantry rotation were allowed, provided the overall trajectory
cost was minimized.
For this study the technique was extended to incorporate mul-
tiple OARs of different relative importance and prevent large or less
important OARs from dominating the cost for a given beam orien-
tation, a limitation of the previous method [16]. The cost, C, for
each orientation is given by the sum of the relative volumes of each
OAR intersected during ray tracing, weighted by their relative
importance (Eq. (1)).
Cc;g ¼
X
m2V
im
nv
Nv
ð1Þ
126 Non-coplanar trajectories for brain VMATwhere an OAR, v, from all clinically important OARs, V, with relative
importance i, has n of N voxels intersected by rays cast from a beam
orientation with couch angle, c, and gantry angle, g. The importance
factors, i, were those used during plan optimization (Supplementary
Table A2) and chosen based on relative clinical priority.Fluence-based local search
One limitation of GH is that individual beam orientation costs,
and therefore trajectories, do not evaluate the effect of fluence
modulation around the arc. In some cases it may be beneficial to
deliver dose to the PTV from beam angles which irradiate through
an OAR, provided modulation is used to reduce the fluence directed
at the OAR e.g. through the contralateral optics. GH would overlook
these high cost beam orientations even if they might be included in
a dosimetrically optimal trajectory. FBLS was developed to investi-
gate the effect on plan dosimetry of local modifications, based on
fluence modulation, to a supplied trajectory.
FBLS was applied to a coplanar VMAT trajectory to determine if
it alone could significantly improve dosimetry. FBLS was also
applied to a GH trajectory to investigate nearby trajectories that,
although not optimal in terms of geometric avoidance over the
whole arc, might improve overall plan dosimetry.FBLS algorithm
The FBLS algorithm (Fig. 1(b)) is described below; further detail
is provided in Supplementary Fig. A1. The initial VMAT trajectory
was downsampled to a 15-beam IMRT arrangement, approxi-
mately equispaced in gantry rotation (Fig. 1(b), step 1). For each
beam orientation, a simplified primary beam model [24] was used
to map the influence of each ray, j, on the dose, D, to a patient
voxel, i, according to Eq. (2).
Dij ¼ SIDSSDþ d
 2
eldw ð2Þ
where SID is the source to isocenter distance, SSD is the source to
patient surface distance, d is the depth of the calculation point, l
is the attenuation coefficient of water for a nominal 6 MV therapeu-
tic beam (0.0495 cm1) and dw is the water equivalent depth of the
calculation point.
Fluence map optimization (FMO) was performed on the
15-beam IMRT plan to characterize the dosimetry of the VMAT tra-
jectory with a similar resolution to Bzdusek et al. [25] for coplanar
VMAT planning. FMO proceeded for 30 iterations of iterative least
squares [21] using the clinical treatment planning objectives
(Supplementary Table A2). The deviation of each objective,
weighted by its corresponding importance factor, was determined
and then summed to form a local search objective function.
The couch rotation of the first beam orientation was perturbed
by a step size of ±10, with new FMO performed, and the change
that most improved the objective function was accepted (Fig. 1
(b), step 2). For each beam in turn, repeated perturbations were
performed and accepted until there was no absolute improvement
in the objective function from adjusting the current beam (Fig. 1
(b), step 3). The perturbation step size was then reduced incremen-
tally from 10 to 2 and the perturbation stage repeated for each
beam at its new couch angle (Fig. 1(b), step 4). The set of all new
beam orientations was then incorporated into the original trajec-
tory using MATLAB’s piecewise cubic hermite polynomial interpo-
lation [26]. Checks were performed to ensure the interpolated
trajectory avoided collision regions and did not extend beyond
the initial arc start and stop gantry angles. Finally, the trajectory
was resampled to maintain the same number of control points as
the input trajectory (Fig. 1(b), step 5).Plan evaluation
Dose statistics were compared for all plans, with OAR doses
judged against relevant QUANTEC constraints [1]. Dose–volume
statistics linked to cognitive performance, V10Gy and V40Gy for the
hippocampi, and V40Gy and V60Gy for the temporal lobes [27], were
also compared. The probability of radiation induced cognitive
impairment, as measured by the Wechsler Memory Scale-III Word
List Delayed Recall (WMS-III WL-DR) test, was calculated from the
equivalent dose in 2 Gy fractions to 40% of the bilateral hippocampi
(EQD2 40%) according to the NTCP model proposed by Gondi et al.
[6]. All plans were compared against monitor units required,
homogeneity index [28] (HI):
HI ¼ D2%  D98%
D50%
 100 ð3Þ
where D2%, D98% and D50% are the doses to 2%, 98% and 50% of the
PTV respectively,
van’t Riet’s conformation number [29] (CN):
CN ¼ VT;95%
VT
 VT;95%
V95%
ð4Þ
where VT is the volume of the PTV, V95% is the volume of the 95% iso-
dose, and VT,95% is the volume of the PTV encompassed by the 95%
isodose, and gradient index (GI):
GI ¼ V50%
V95%
ð5Þ
where V50% and V95% are the volumes of the 50% and 95% isodoses
respectively.
Statistical analysis was performed using a two-tailed Wilcoxon
signed-rank matched-pairs test in SPSS (v22, IBM Corporation,
Armonk, New York), with comparisons judged significant if
p < 0.05. Single and dual arc coplanar VMAT were compared to
determine if adding additional control points significantly
improved the plans produced. All three non-coplanar techniques
were compared with coplanar VMAT. The effect of combining the
two optimization approaches was determined by comparing GH
with FBLS + GH.
Results
Dual arc coplanar plans were not significantly different from
single arc coplanar for most metrics studied (Supplementary
Table A3). However, the contralateral optic nerve, hippocampus
and temporal lobe, and body excluding PTV dose statistics and gra-
dient index showed modest improvements. In all cases where met-
rics were improved by dual arc planning, statistical significance
tests against non-coplanar VMAT were unaffected by the number
of coplanar arcs. As the number of control points used for single
arc coplanar plans (180) was similar to non-coplanar plans (med-
ian 180, range 180 – 202 for GH and FBLS + GH; 180 for FBLS),
remaining comparisons are against single arc coplanar VMAT only.
Coronal sections through all plans for a representative patient
case are presented in Fig. 2. Note how the orientation of the iso-
dose levels in the non-coplanar plans differs from the coplanar case
to avoid the OARs, particularly for the 50% and 20% isodoses. Tra-
jectories for all plans for one patient case are shown in Fig. 3 over-
laid on the cost map of the geometric heuristic technique. Regions
of the cost map with high cost indicate beam orientations where a
large proportion of clinically important organs at risk would be
irradiated by a beam aperture conforming to the projection of
the PTV. Low cost regions indicate beam orientations where no
OARs, or a small proportion of low importance OARs, would be
irradiated. Potential collision regions, estimated with a volunteer
lying on the treatment couch, are shown in white.
Fig. 2. Coronal sections for Case 4, showing plans for (a) coplanar VMAT, (b) the
geometric heuristic technique (GH), (c) the fluence-based local search (FBLS), and
(d) the combination of GH and FBLS (FBLS + GH). PTV (pink colorwash), hippocam-
pus (orange), temporal lobe (yellow), brainstem (red), and cochlea (purple) are
shown. Isodose lines are 95% (green), 80% (blue), 50% (lilac), and 20% (brown) of
prescription dose.
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Fig. 3. VMAT trajectories for (a) the geometric heuristic technique (GH), (b)
fluence-based local search (FBLS), and (c) and the combination of GH and FBLS
(FBLS + GH). All trajectories are overlaid on the normalized cost map for the
geometric heuristic technique. White regions indicate excluded potential collision
regions; high cost regions indicate orientations where a beam aperture conforming
to the PTV would irradiate multiple or high importance organs at risk.
G. Smyth et al. / Radiotherapy and Oncology 121 (2016) 124–131 127Mean relative dose or volume deviations of clinically relevant
OAR statistics from the coplanar VMAT plan are presented in
Fig. 4, with negative values indicating reductions and error bars
indicating ±1 standard deviation. Complete results, including abso-
lute dose statistics and statistical comparisons, are presented in
Table 1. All three non-coplanar trajectory optimization techniques
significantly reduced doses to the contralateral globe, optic nerve,
hippocampus (mean dose and V40Gy), temporal lobe (mean dose
and V40Gy), and cochlea. Additionally GH and FBLS + GH signifi-
cantly reduced the contralateral lens dose and contralateral hip-
pocampus V10Gy; GH also reduced the mean brainstem dose. FBLS
significantly increased doses to the ipsilateral globe, optic nerve
(mean), and lens. Compared to GH, FBLS + GH significantly
increased dose to the brainstem, contralateral optics, ipsilateral
hippocampus (mean dose and V40Gy), ipsilateral temporal lobe
(mean), and body excluding PTV.
PTV homogeneity index increased for GH (p = 0.004) and FBLS
+ GH (p = 0.013) plans compared with coplanar VMAT. However,
FBLS + GH improved homogeneity over GH (p = 0.009). PTV cover-
age was less conformal for GH (p = 0.033), FBLS (p = 0.002), and
FBLS + GH (p = 0.015) compared with coplanar VMAT. Gradient
index was improved by FBLS (p = 0.001) and FBLS + GH
(p = 0.029) plans compared with coplanar; FBLS + GH plans also
improved over GH (p = 0.004). Non-coplanar plans required more
monitor units than coplanar VMAT (p = 0.001 for all techniques)
but there was no difference between GH and FBLS + GH.Predicted clinical effect
Whole body D1cc to patients with 59.4 Gy and 60 Gy prescrip-
tions exceeded 60 Gy for all techniques (maximum 63.5 Gy),
suggesting a risk of brain necrosis of 3–5% [2]. Although
non-coplanar techniques showed small increases in D1cc, theseare unlikely to result in clinically significant differences in symp-
tomatic necrosis risk. No patient received 59 Gy to more than
10 cc of the brainstem, complying with QUANTEC constraints [1].
QUANTEC optic nerve or chiasm constraints (maximum
dose < 55 Gy) were exceeded in eight patients. Constraints were
exceeded for the ipsilateral optic nerve in four patients, and the
contralateral optic nerve in one patient, for all coplanar and non-
coplanar plans. For patient 2, the ipsilateral optic nerve maximum
dose increased to 55.3 Gy for GH from 54.8 Gy for coplanar VMAT,
but reduced to 54.4 Gy with FBLS + GH. Seven patients exceeded
the optic chiasm constraint, of which five exceeded the constraint
for all coplanar and non-coplanar plans. For patient 4, the maxi-
mum chiasm dose increased to 56.6 Gy and 55.8 Gy for GH and
FBLS + GH respectively from the initial coplanar VMAT dose of
54.4 Gy. For patient 6, the maximum chiasm dose was reduced to
below the constraint for all non-coplanar plans from the initial
coplanar VMAT dose of 55.1 Gy. QUANTEC suggests the threshold
for optic neuropathy may be 59 Gy for non-pituitary tumors at
these fraction sizes [4]. One case with a prescription dose of
60 Gy (patient 8) exceeded 59 Gy to the ipsilateral optic nerve
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Fig. 4. Mean relative deviations from single arc VMAT of clinically relevant organ at risk (a) maximum dose, (b) mean dose, and (c) dose–volume statistics for the geometric
heuristic technique (GH), fluence-based local search (FBLS), and combined GH and FBLS (FBLS + GH). Error bars show ± 1 standard deviation. Vx = relative volume receiving x
Gy; I. = ipsilateral; C. = contralateral; temp. = temporal lobe; hippo. = hippocampus.
128 Non-coplanar trajectories for brain VMATand chiasm; this was breached for all plans including coplanar
VMAT. None of these changes in dose would be expected to signif-
icantly affect the likelihood of radiation induced optic neuropathy.There was no difference in the number of patients breaching the
QUANTEC cochlear dose constraints between techniques at either
the standard 45 Gy or conservative 35 Gy levels, corresponding to
Table 1
Mean and standard deviations of dose statistics for coplanar and geometric heuristic technique (GH), fluence-based local search (FBLS), and combined GH and FBLS (FBLS + GH)
non-coplanar VMAT trajectories. Significant statistical comparisons (p < 0.05) are indicated as follows: (a) coplanar vs GH, (b) coplanar vs FBLS, (c) coplanar vs FBLS + GH, (d) GH
vs FBLS + GH, (e) GH vs FBLS, (f) FBLS vs FBLS + GH. Ipsi and contra = ipsilateral and contralateral. Dx = dose to volume x. VxGy = relative volume receiving x Gy.
Region of interest/metric Statistic Mean ± 1 S.D. Significant tests
Coplanar GH FBLS FBLS + GH
D98% (Gy) 54.6 ± 3.0 54.4 ± 2.9 54.6 ± 2.9 54.5 ± 2.9 a, d, e
PTV D50% (Gy) 56.8 ± 3.1 56.8 ± 3.1 56.9 ± 3.1 56.8 ± 3.1
D2% (Gy) 58.2 ± 3.2 58.5 ± 3.1 58.3 ± 3.2 58.5 ± 3.2 a, c, e, f
Brainstem DMax (Gy) 54.7 ± 4.6 54.7 ± 4.9 54.5 ± 4.0 55.0 ± 4.6 d
DMean (Gy) 29.3 ± 12.5 25.1 ± 13.8 27.7 ± 12.5 26.4 ± 13.5 a, d, e
Ipsi. Globe DMax (Gy) 25.0 ± 12.1 27.8 ± 12.3 27.7 ± 12.9 27.9 ± 12.4 b
DMean (Gy) 16.2 ± 7.7 17.8 ± 8.3 17.9 ± 8.0 17.9 ± 8.5 b
Contra. Globe DMax (Gy) 19.3 ± 6.6 11.5 ± 9.2 16.1 ± 5.9 12.9 ± 9.7 a, b, c, d, e
DMean (Gy) 13.3 ± 5.0 6.0 ± 5.8 11.3 ± 4.2 7.4 ± 6.4 a, b, c, d, e, f
Ipsi. Optic Nerve DMax (Gy) 41.9 ± 15.5 42.7 ± 15.2 43.2 ± 14.5 42.7 ± 15.1
DMean (Gy) 29.9 ± 12.3 31.5 ± 13.1 32.5 ± 12.4 31.5 ± 13.3 b
Contra. Optic Nerve DMax (Gy) 34.6 ± 13.6 25.9 ± 18.5 31.7 ± 14.5 27.5 ± 17.8 a, b, c, d, e
DMean (Gy) 22.3 ± 7.8 12.9 ± 10.3 18.9 ± 7.2 14.7 ± 10.6 a, b, c, d, e, f
Chiasm DMax (Gy) 51.2 ± 9.3 50.4 ± 10.5 50.7 ± 9.8 50.7 ± 10.2
Ipsi. Lens DMax (Gy) 15.2 ± 7.3 17.0 ± 6.9 16.5 ± 7.4 16.8 ± 7.3 b
DMean (Gy) 12.8 ± 6.5 14.6 ± 6.4 14.1 ± 6.4 14.3 ± 6.5 b
Contra. Lens DMax (Gy) 13.2 ± 5.1 6.5 ± 5.7 11.5 ± 4.5 7.9 ± 6.4 a, c, d, e, f
DMean (Gy) 11.1 ± 4.7 5.0 ± 4.7 9.8 ± 4.2 6.3 ± 5.5 a, c, d, e, f
Ipsi. Hippocampus DMean (Gy) 46.7 ± 14.8 44.9 ± 17.9 46.8 ± 14.9 46.0 ± 16.7 d
V10Gy (%) 97.3 ± 9.4 92.9 ± 25.6 97.1 ± 11.2 94.6 ± 20.4
V40Gy (%) 74.0 ± 41.9 71.9 ± 42.8 73.8 ± 42.6 73.0 ± 43.1 d, e
Contra. Hippocampus DMean (Gy) 30.4 ± 9.5 13.4 ± 10.7 24.0 ± 10.0 15.0 ± 10.7 a, b, c, e, f
V10Gy (%) 97.0 ± 11.5 48.2 ± 38.6 88.3 ± 26.6 56.0 ± 39.8 a, c, e, f
V40Gy (%) 16.3 ± 22.2 6.3 ± 16.5 8.2 ± 18.1 6.3 ± 15.9 a, b, c, e, f
Ipsi. Temporal Lobe DMean (Gy) 41.5 ± 15.9 39.1 ± 20.2 41.6 ± 16.6 39.6 ± 19.8 d
V40Gy (%) 59.7 ± 38.2 60.7 ± 39.6 60.6 ± 38.8 60.9 ± 39.5
V60Gy (%) 12.0 ± 21.8 15.9 ± 25.7 13.1 ± 21.6 16.1 ± 26.2
Contra. Temporal Lobe DMean (Gy) 23.6 ± 7.2 7.3 ± 4.9 16.6 ± 6.5 8.4 ± 5.3 a, b, c, e, f
V40Gy (%) 5.0 ± 6.0 1.8 ± 3.8 2.6 ± 4.7 1.8 ± 3.8 a, b, c, e, f
V60Gy (%) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Ipsi. Cochlea DMean (Gy) 27.8 ± 22.5 26.4 ± 22.6 29.3 ± 21.1 27.4 ± 21.8 e
Contra. Cochlea DMean (Gy) 12.9 ± 8.4 4.8 ± 3.9 9.3 ± 5.7 5.4 ± 4.2 a, b, c, e, f
Body excluding PTV DMean (Gy) 11.6 ± 4.2 11.4 ± 3.6 11.5 ± 4.1 11.5 ± 3.7 d
Body D1cc (Gy) 58.4 ± 3.4 58.9 ± 3.3 58.5 ± 3.3 58.8 ± 3.3 a, c, e, f
Monitor units 238.7 ± 15.7 260.4 ± 21.6 241.6 ± 15.7 259.4 ± 20.8 a, b, c, e, f
Homogeneity index (%) 6.308 ± 0.846 7.285 ± 1.046 6.382 ± 1.023 6.929 ± 1.020 a, c, d, e, f
Gradient index 2.708 ± 0.700 2.610 ± 0.769 2.473 ± 0.714 2.524 ± 0.784 b, c, d
Conformation number 0.791 ± 0.064 0.775 ± 0.065 0.779 ± 0.070 0.770 ± 0.072 a, b, c
G. Smyth et al. / Radiotherapy and Oncology 121 (2016) 124–131 129a 30% chance of hearing loss. However, the significant reduction in
contralateral cochlear dose demonstrated by the non-coplanar
techniques could reduce the likelihood of hearing loss.
Dose–volume histograms (DVH) of the contralateral hippocam-
pus and temporal lobe for three representative patient cases are
shown in Fig. 5. Contralateral hippocampus and temporal lobe
V40Gy were significantly reduced by all non-coplanar techniques,
while contralateral hippocampus V10Gy was reduced by GH and
FBLS + GH. Median overlap of the bilateral hippocampi with the
PTV was 29.2% (range 0–59.5%), with six patients having an overlap
of more than 40%. The probability of cognitive impairment for GH
plans (mean ± 1 S.D., 0.875 ± 0.263) was significantly reduced from
coplanar VMAT (0.936 ± 0.183, p = 0.028). FBLS + GH significantly
increased cognitive impairment probability (0.898 ± 0.229,
p = 0.028) over GH, but remained significantly reduced over copla-
nar VMAT (p = 0.043).
Discussion
This work evaluates three non-coplanar VMAT trajectory opti-
mization techniques for a cohort of primary brain tumor patients.
Having performed a systematic comparison of these techniques,
alone and in combination, we can draw some specific conclusions
regarding their relative merits. FBLS achieved additional contralat-
eral OAR sparing over coplanar VMAT, while maintaining PTV
homogeneity, but increased dose to ipsilateral OARs. FBLS + GHmaintained much of the OAR sparing of GH while recovering some
lost PTV dose homogeneity. The trade-off between PTV dose homo-
geneity and OAR sparing depends on the planning objectives used,
while the extent to which individual OARs are spared depends on
their relative importance for the specific clinical case. For this
cohort, it is important to maximize OAR sparing and therefore
the geometric heuristic technique is recommended for primary
brain tumors.
Recent work has proposed different heuristic or fluence-based
methods of trajectory optimization [10,16–19]. Fluence-based
techniques solved non-coplanar IMRT beam orientation problems
for up to 20 beams but did not evaluate the dosimetry of the con-
necting paths [18,19]; therefore the final VMAT trajectories may
not be globally optimal. FBLS accepted only local changes that
decreased the local search objective function and therefore did
not guarantee the altered VMAT trajectory was optimal. However,
it did allow the dosimetry of alternate trajectories to be investi-
gated while maintaining the quality of the rest of the connected
trajectory. The complexity of FBLS was limited by using a simpli-
fied beammodel; further work to incorporate a clinical dose model
and determine its effect on trajectory optimization is planned.
More general issues regarding the potential clinical implemen-
tation of dynamic couch non-coplanar VMAT have yet to be fully
addressed. While modern linear accelerators can deliver non-
coplanar VMAT [10,17], there has been no systematic investigation
of its delivery accuracy or efficiency. Although statistically
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Fig. 5. PTV and contralateral hippocampus (a, c, e) and contralateral temporal lobe (b, d, f) dose–volume histograms for the geometric heuristic technique (GH), fluence-based
local search (FBLS), and combined GH and FBLS (FBLS + GH), for representative patient cases with small (top; Case 1), medium (middle; Case 9), and large (bottom; Case 15)
PTV volumes.
130 Non-coplanar trajectories for brain VMATsignificant, coplanar and non-coplanar monitor units were suffi-
ciently similar that we expect delivery efficiency to depend on
couch rotation speed. Potential differences in delivery efficiency
between non-coplanar trajectories will depend on gantry rotation,
couch rotation, and dose rate limits for the specific machine.
Dynamic couch rotation requires extra quality assurance testing
[30] and advanced collision prediction and detection methods
[31]. Patient rotation during treatment could introduce intra-
fractional motion, with the effect dependent on treatment site
and couch trajectory. Although additional immobilization is
unlikely to be necessary for intracranial treatments, this may be
a significant issue for other body sites and requires investigation.
An alternative linac configuration capable of rotation around the
vertical axis allows non-coplanar treatment without patient move-
ment and would address some of these problems [32,33]. However,
the reduced range of rotation achievable [32] may limit the utility
of this approach for intracranial sites. The trajectory optimization
techniques described in this work are applicable to all delivery
platforms, within machine limitations.
Non-coplanar VMAT demonstrated improved sparing of func-
tionally important OARs, notably significantly decreasing dose to
the contralateral temporal lobe and hippocampus (Fig. 5). Neu-
rocognitive decline has been linked to higher doses to the hip-
pocampi [6,27,34,35] and temporal lobes [27,34,36]. Redmondet al. found reductions in children’s motor speed and dexterity
were correlated with increased dose to the hippocampi and tempo-
ral lobes, while visual perception decreased with increasing dose to
the left temporal lobe [34]. Jalili et al. found children and young
adults receiving greater than 43.2 Gy to 13% of the left temporal
lobe were significantly more likely to demonstrate a reduction in
intelligence quotient (IQ) of 10% or more [36]. The effect of hip-
pocampal sparing in whole brain radiotherapy is currently under
active investigation in several clinical trials worldwide, and has
shown promising results in the RTOG 0933 phase 2 trial [35].
Gondi et al. modeled the probability of impaired learned-word
recall with increasing dose to the hippocampi for a cohort of adult
patients [6]. Gondi et al.’s NTCP model of cognitive injury due to
hippocampal dose results in a rather stringent hippocampal dose
sparing requirement (D40% to the bilateral hippocampi leading to
a 50% probability of WMS-III WL-DR impairment (EQD502 ) was esti-
mated to be 14.88 Gy [95% CI, 12.86–17.06 Gy]) that may be difficult
to achieve in practice for patients treated for primary brain tumors
where intra-cranial tumor control is the priority. While the modeled
hippocampal NTCP reductions achieved by non-coplanar VMAT were
modest, the absolute dose reductions achieved for the contralateral
temporal lobe and hippocampus (Fig. 5) are likely to be clinically sig-
nificant [27]. These studies suggest that non-coplanar VMAT using
dynamic couch rotation should reduce the incidence and severity
G. Smyth et al. / Radiotherapy and Oncology 121 (2016) 124–131 131of neurocognitive side effects by limiting dose to the contralateral
temporal lobe and hippocampus. The potential benefit of non-
coplanar VMAT for a homogeneous cohort of primary brain tumor
patients should now be evaluated within a clinical trial.
Conclusions
Non-coplanar VMAT trajectories using GH significantly spared
contralateral OARs over coplanar VMAT for primary brain tumors.
Both fluence-based trajectories emphasized PTV homogeneity over
OAR sparing, although FBLS + GH maintained most of the OAR
sparing achieved by GH. However, for primary brain tumor
patients, organ at risk sparing is clinically more important than
the relatively small differences in PTV homogeneity. Therefore,
non-coplanar VMAT using the geometric heuristic technique is rec-
ommended to reduce normal tissue complication probability for
primary brain tumor patients.
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